Correlation Between Prelude Therapeutics and Pyxis Oncology
Can any of the company-specific risk be diversified away by investing in both Prelude Therapeutics and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prelude Therapeutics and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prelude Therapeutics and Pyxis Oncology, you can compare the effects of market volatilities on Prelude Therapeutics and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prelude Therapeutics with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prelude Therapeutics and Pyxis Oncology.
Diversification Opportunities for Prelude Therapeutics and Pyxis Oncology
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Prelude and Pyxis is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Prelude Therapeutics and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Prelude Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prelude Therapeutics are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Prelude Therapeutics i.e., Prelude Therapeutics and Pyxis Oncology go up and down completely randomly.
Pair Corralation between Prelude Therapeutics and Pyxis Oncology
Given the investment horizon of 90 days Prelude Therapeutics is expected to generate 1.22 times less return on investment than Pyxis Oncology. In addition to that, Prelude Therapeutics is 3.05 times more volatile than Pyxis Oncology. It trades about 0.09 of its total potential returns per unit of risk. Pyxis Oncology is currently generating about 0.34 per unit of volatility. If you would invest 136.00 in Pyxis Oncology on August 27, 2025 and sell it today you would earn a total of 398.00 from holding Pyxis Oncology or generate 292.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prelude Therapeutics vs. Pyxis Oncology
Performance |
| Timeline |
| Prelude Therapeutics |
| Pyxis Oncology |
Prelude Therapeutics and Pyxis Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prelude Therapeutics and Pyxis Oncology
The main advantage of trading using opposite Prelude Therapeutics and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prelude Therapeutics position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.| Prelude Therapeutics vs. Sunlands Technology Group | Prelude Therapeutics vs. Natcore Technology | Prelude Therapeutics vs. Gamma Communications plc | Prelude Therapeutics vs. Casio Computer Co |
| Pyxis Oncology vs. Doman Building Materials | Pyxis Oncology vs. Compagnie Plastic Omnium | Pyxis Oncology vs. Eagle Materials | Pyxis Oncology vs. Kossan Rubber Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |